# PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial

> **NCT06301477** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Children's Hospital of Eastern Ontario** · enrollment: 45 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Crohn Disease

## Interventions

- **OTHER:** Resistant Starch
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06301477
- **Lead sponsor:** Children's Hospital of Eastern Ontario
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-08
- **Final completion:** 2027-03-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06301477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06301477, "PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial". Retrieved via AI Analytics 2026-07-21 from https://api.ai-analytics.org/clinical/NCT06301477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*